Physician profile
Payal A Patel
NPI 1730676693
$1,844.76
in general payments reported to CMS, 2019-2025
13 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $100 · 2022: $783 · 2023: $619 · 2024: $190 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $537 · Travel and Lodging: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.78 |
| Travel and Lodging | $424.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eclipse Technology Solutions INC. | $837.19 | 2022-2024 | |
| Arthrex, INC. | $468.48 | 2023 | |
| Stryker Corporation | $200.20 | 2021-2024 | Augment Injectable |
| Paratek Pharmaceuticals, INC. | $147.26 | 2023-2025 | Nuzyra |
| Orthofix Medical, INC. | $37.61 | 2024-2025 | Physio-Stim |
| Averitas Pharma INC. | $33.07 | 2024 | Qutenza |
| Treace Medical Concepts, INC. | $24.99 | 2024 | |
| Solventum Corporation | $22.38 | 2025 | Activ.A.C., Kerramax Care, Promogran Prisma |
| Medtronic, INC. | $19.15 | 2025 | Inceptiv |
| Convatec INC. | $14.83 | 2023 | |
| Grt US Holding, INC. | $14.60 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.62 | 2023 | Jublia |
| Biotissue Holdings INC. | $11.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Payal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.